Virologica Sinica

, 24:518 | Cite as

An improved strategy for efficient expression and purification of soluble HIV-1 tat protein in E.coli

  • Shi-meng Zhang
  • Rong Fan
  • Tian-yi Yang
  • Yi Sun
  • Jing-yun Li
  • Qin-zhi Xu
  • Ping-kun Zhou
Article

Abstract

Although the endogenous function of Tat has been elucidated in the past twenty years, the study of its exogenous activity has been hampered due to the difficulty of large scale preparation of the active Tat protein. To express the full-length Tat protein in E.coli, the tat gene was cloned from an HIV infected patient by overlapping PCR. Rare codon usage analysis showed that rare E.coli codons, especially consecutive rare codons for Arg, account for 14% (14 of 101) rare E.coli codons in the tat gene. The expression of the HIV-1 tat gene was verified to be very poor in strain BL21 (DE3) due to the abundance of rare codons; however, tat gene expression was found to be very efficient in the host strain of Rosetta-gami B (DE3), which was supplemented with six rare tRNAs for Arg, Leu, Ile and Pro. Subsequent purification revealed that the proteins are soluble and unusually, the tagged Tat can form dimers independent of cystine disulfide bonds. The purity, integrity and molecular weight of the Tat protein were demonstrated by MALDI-TOF mass spectrometry. Reporter gene activating assay was further confirmed by investigating the transactivation activity of the recombinant Tat protein. Our improved strategy for efficient high level expression and purification of soluble Tat protein has paved the way to fully investigate its exogenous function.

Key words

HIV tat gene E.coli Protein expression Codon usage 

CLC number

R373 

Reference

  1. 1.
    Barboric M, Peterlin B M. 2005, A new paradigm in eukaryotic biology, HIV Tat and the Control of Transcriptional Elongation. PLoS Biol, 3: e76.CrossRefPubMedGoogle Scholar
  2. 2.
    Bayer P, Kraft M, Ejchart A, et al. 1995, Structural Studies of HIV-1 Tat Protein. J MoL Biol, 247:529–535.PubMedGoogle Scholar
  3. 3.
    Brigati C, Giacca M, Noonan D M, et al. 2003, HIV Tat, its targets and the control of viral gene expression. FEMS Microbiol Lett, 220: 57–65.CrossRefPubMedGoogle Scholar
  4. 4.
    Brinkmann U, Mattes R E, Buckel P. 1989, High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene, 85: 109–114.CrossRefPubMedGoogle Scholar
  5. 5.
    Brorson J R, Manzolillo P A, Gibbons S J, et al. 1995, AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci, 15: 4515–4524.PubMedGoogle Scholar
  6. 6.
    Chen G T, Inouye M. 1994, Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. Genes Dev. 8: 2641–2652.CrossRefPubMedGoogle Scholar
  7. 7.
    Dayton A I, Sodroski J G, Rosen C A, et al. 1986, The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell, 44: 941–947.CrossRefPubMedGoogle Scholar
  8. 8.
    Del Tito B J Jr, Ward J M, Hodgson J, et al. 1995, Effects of a Minor Isoleucyl tRNA on Heterologous Protein Translation in Escherichia coli. J Bacteriol, 177: 7086–7091.PubMedGoogle Scholar
  9. 9.
    Dingwall C, Ernberg I, Gait M J, et al. 1989, Human immunodeficiency virus 1 tat protein binds trans-activation- responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA, 86: 6925–6929.CrossRefPubMedGoogle Scholar
  10. 10.
    Ensoli B, Buonaguro L, Barillari G, et al. 1993, Release, uptake and effects of extracellular HIV-1 tat protein on cell growth in viral transactivation. J Virol, 67: 277–287.PubMedGoogle Scholar
  11. 11.
    Frankel A D, Bredt D S, Pabo C O. 1988, Tat protein from human immunodeficiency virus forms a metal-linked dimmer. Science, 240: 70–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Gaynor R. 1992, Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS, 6: 347–363.CrossRefPubMedGoogle Scholar
  13. 13.
    Gentz R, Chen C H, Rosen C A. 1989, Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: Trans-activation requires mRNA synthesis. Proc Natl Acad Sci USA, 86:821–824.CrossRefPubMedGoogle Scholar
  14. 14.
  15. 15.
    Kim S, Lee S B. 2006, Rare codon clusters at 5′-end influence heterologous expression of archaeal gene in Escherichia coli. Protein Expr Purif, 50: 49–57.CrossRefPubMedGoogle Scholar
  16. 16.
    Kirsch T, Boehm M, Schuckert O, et al. 1996, Cloning, High-Yield Expression in Escherichia coli, and Purification of Biologically Active HIV-1 Tat Protein. Protein Expr Purif, 8: 75–84.CrossRefPubMedGoogle Scholar
  17. 17.
    Kleber-Janke T, Becker W M. 2000, Use of modified BL21(DE3) Escherichia coli cells for high-level expression of recombinant peanut allergens affected by poor codon usage. Protein Expr Purif, 19: 419–424.CrossRefPubMedGoogle Scholar
  18. 18.
    Magnuson D S, Knudsen B E, Geiger J D, et al. 1995, Human immuno- deficiency virus type I Tat activates non-N-methyl-d-aspartate excitatory aminoacid receptors and causes neurotoxicity. Ann Neurol, 37: 373–380.CrossRefPubMedGoogle Scholar
  19. 19.
    McKenna M C, Muchardt C, Gaynor R, et al. 1994, Preparative scale culture of Escherichia coli cells expressing the human immunodeficiency virus type 1 Tat protein. Protein Expr Purif, 5: 105–111.CrossRefPubMedGoogle Scholar
  20. 20.
    Rice A P, Mathews M B. 1988, Transcriptional but not translational regulation of HIV-1 by the tat gene product. Nature, 332: 551–553.CrossRefPubMedGoogle Scholar
  21. 21.
    Rosen C A, Sodroski J G, Haseltine W A. 1985, The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell, 41: 813–823.CrossRefPubMedGoogle Scholar
  22. 22.
    Rosenberg A H, Goldman E, Dunn J J, et al. 1993, Effects of Consecutive AGG Codons on Translation in Escherichia coli, Demonstrated with a Versatile Codon Test System. J. Bacteriol, 175: 716–722.PubMedGoogle Scholar
  23. 23.
    Ruben S, Perkins A, Purcell R, et al. 1989, Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol, 63: 1–8.PubMedGoogle Scholar
  24. 24.
    Rusnati M, Presta M. 2002, HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis, 5: 141–151.CrossRefPubMedGoogle Scholar
  25. 25.
    Seidel H M, Pompliano D L, Knowles J R. 1992, Phosphonate biosynthesis: molecular cloning of the gene for phosphoenolpyruvate mutase from Tetrahymena pyriformis and overexpression of the gene product in Escherichia coli. Biochemistry, 31: 2598–2608.CrossRefPubMedGoogle Scholar
  26. 26.
    Twyman R E, Gahring L C, Spiess J, et al. 1995, Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron, 14: 755–762.CrossRefPubMedGoogle Scholar
  27. 27.
    Zdanovsky A G, Zdanovskaia M V. 2000, Simple and Efficient Method for Heterologous Expression of Clostridial Proteins. Appl Environ Microbiol, 66: 3166–3173.CrossRefPubMedGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer Berlin Heidelberg 2009

Authors and Affiliations

  • Shi-meng Zhang
    • 1
  • Rong Fan
    • 1
  • Tian-yi Yang
    • 1
  • Yi Sun
    • 1
  • Jing-yun Li
    • 2
  • Qin-zhi Xu
    • 1
  • Ping-kun Zhou
    • 1
  1. 1.The Department of Radiation Toxicology and OncologyBeijing Institute of Radiation MedicineBeijingChina
  2. 2.Institute of Microbiology and EpidemiologyBeijingChina

Personalised recommendations